Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annu...( IRVINE Calif. Oct. 20 /- Alsius C...),Health

IRVINE, Calif., Oct. 20 /PRNewswire-FirstCall/ -- Alsius Corporation (Nasdaq: ALUS), the worldwide leader in intravascular temperature management (IVTM(TM)) therapies, today announced that four scientific posters featuring both patient cases and laboratory research in which the Thermogard XP(TM) was utilized will be presented this week at the American Society of Anesthesiologists (ASA) Annual Meeting, taking place in Orlando.

Dr. Arie Blitz, Director of Heart Transplantation and Assist Device Surgery at University Hospitals of Cleveland Case Medical Center, and President of the Cleveland chapter of the American Heart Association, will present the following posters highlighting the use of the Thermogard XP in challenging cardiac surgery cases:

-- Use of a Novel Percutaneous Warming Catheter as a Protection Against Perioperative Hypothermia

-- Perioperative Therapeutic Hypothermia for Intraoperative Cardiac Arrest During Cardiac Surgery

-- Use of a Warming Catheter To Treat Perioperative Hypothermia in a Patient Undergoing Salvage Off-Pump RVAD Insertion

-- Reversal of Stroke by the Early Institution of Therapeutic Hypothermia after Cardiac Surgery

"Patients undergoing cardiac surgery are at risk for developing a variety of perioperative complications, including hypothermia and stroke," commented Dr. Blitz, senior author of the case studies to be featured at ASA. "Precise control of body temperature plays an important role in treating patients who are at risk for these complications.

"Patients who experience inadvertent hypothermia during surgery are at increased risk for bleeding and other adverse events, and therefore may benefit by being kept warm during the course of the operation," conti
'/>"/>